Continuous technological advancements in automation solutions, increasing government financial support for medical automation, rising labour costs, and growing need for reproducibility and accuracy are key factors fuelling the growth of the medical automation market. Increasing demand for automation in laboratories and pharmacies and high potential for early detection and treatment of diseases due to automation are some other prime factors offering growth opportunities for players in the medical automation market. However, high cost of automation is one of the key restraints for this market.
The global medical automation market is divided into four segments on the basis of end users– hospitals and diagnostic centers, pharmacies, research laboratories and institutes, and home/ambulatory care settings and other end users.
The therapeutic automation market segment holds the largest share in the global medical automation market. This segment is further categorized on the basis of product into non-surgical automation (defibrillators and automated medication systems) and surgical automation (surgical robots, intraoperative imaging, surgical navigation, intelligent operating rooms, and surgical simulators). In 2015, the non-surgical automation segment held a larger share of 72.9% of the global therapeutic automation market. The increasing incidences of various chronic diseases and technological advancements in defibrillators and medication systems are the key factors contributing to the growth of this market segment.
New product launches, product approvals, and product enhancements is the primary growth strategy adopted by major players to enhance their positions in the global medical automation market. Moreover, strategies such as partnerships, agreements, and collaborations; geographic expansions; and acquisitions were also adopted by a significant number of market players to strengthen their product portfolios and expand their geographic presence in the market.
On the basis of geography, medical automation market is classified into four regions, namely, North America (U.S. and Canada), Europe, Asia-Pacific, and the Rest of the World. In 2015, the global medical automation market is estimated to be dominated by North America. Large number of ongoing clinical trials in the U.S., high adoption rate of technologically advanced medical devices in this region, and developed healthcare reimbursement structure are contributing to the large share of the North American medical automation market. The Asia-Pacific market is expected to grow at the highest CAGR
Factors such as growing government expenditure on healthcare research, rising number of clinical research activities owing to increasing R&D outsourcing to developing Asian countries, increasing old age population and associated diseases, availability of a large patient pool, and developing healthcare infrastructure are propelling the growth of the Asia-Pacific medical automation market.
Koninklijke Philips N.V. (Netherlands), Siemens AG (Germany), General Electric Company (U.S.), Intuitive Surgical, Inc. (U.S.), Stryker Corporation (U.S.), Accuray Incorporated (U.S.), Danaher Corporation (U.S.), and Swisslog Holding AG (Switzerland) are some of the key players in the medical automation market.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
